Effect of Febrile Neutropenia Guideline’s Implementation on Death Rate in Dharmais Cancer Center Hospital
Abstract
Keywords
Full Text:
PDFReferences
Naurois J, Basso N, Gill MJ, et al. Management of Febrile Neutropenia: ESMO Clinical Clinical Practice Guideline. Annals of Oncology. 2010; 21(5): 252-6.
Thursky KA, Worth LJ. Can mortality of cancer patients with fever and neutropenia be improved?. Wolters Kluwer Health, Inc. 2015; 28(6): 505-13.
Kyriacou DN, Jovanovic B, Frankfurt O. Timing of initial antibiotic treatment for febrile neutropenia in the emergency department the need for evidence-based guidelines. JNCCN. 2014; 12(11): 1569-73.
Penack O, Buchheidt D, Christopeit M, et al. Management of sepsis in neutropenic patients: guidelines form the infections disease working party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol. 2014; 93: 1083-95.
Ranuhardy D. Panduan Tata Laksana Febril Neutropenia/Demam Neutropeni pada Pasien Kanker. Jakarta: Balai Penerbit FKUI; 2006.
Ranuhardy D, Sandy D. Febrile Neutropeni pada Pasien Kanker di Rumah Sakit Kanker Dharmais, Evaluasi Keadaan Tahun 2009 (Studi Retropektif). (Unpublished); 2009.
Lustberg MB. Management of neutropenia in cancer patients. Clinical Advance in Hematology Oncology 2012;10(12):825–6.
Djasri, Hanevi. Pemilihan dan Penerapan Pedoman Klinis (Clinical Practice Guideline). Yogyakarta: Bahan Kuliah Audit Klinik MMR; 2011.
Kern, Wifried V. Current Epidemiology of Infections in Neutropenic Cancer Patients. In Textbook of Febrile Neutropenia. Kennet VT Rolston, Edward B. Rubenstein (Eds). UK: Martin Dunitz Ltd; 2001. p 57-8.
Lyman GH, Rolston KV. How we treat febrile neutropenia in patients receiving cancer chemotherapy. J Oncol Pract. 2010; 6: 149–52.
Meisenberg B, Clemons J, Ness J, et al. Improving hospital performance in the treatment of febrile neutropenia. Support Care Cancer. 2015; 23: 371-5.
DOI: http://dx.doi.org/10.7454/arsi.v4i3.2551
Refbacks
- There are currently no refbacks.